Glaukos (GKOS) Long-Term Debt Repayments (2015)

Glaukos (GKOS) reported Long-Term Debt Repayments of $6.9 million for Q1 2015.

Glaukos (GKOS) Long-Term Debt Repayments (2015) Analysis & Trends

Glaukos (GKOS) has 1 years of Long-Term Debt Repayments data on file, last reported at $6.9 million in Q1 2015.

  • Long-Term Debt Repayments for Q1 2015 came in at $6.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $6.9 million (changed N/A YoY), and the FY2024 annual result was $712000.0, changed N/A from the prior year.
  • Long-Term Debt Repayments held at $6.9 million in Q1 2015 per GKOS's latest filing.
  • Over five years, Long-Term Debt Repayments peaked at $6.9 million in Q1 2015 and troughed at $6.9 million in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 1.00 Bn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn -
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn -
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn -
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn -
10 Glaukos 7.08 Bn 6.98 Bn 117.23 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2015 6.85 Mn
Mar 31, 2015 6.85 Mn